About BIO-key International (NASDAQ:BKYI)
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver's licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing. Its solutions identify individuals and verify, or confirm, their identity before granting access to, among other things, corporate resources, subscribed data and services, Web portals, applications, physical locations or assets.
Industry, Sector and Symbol:
- Industry: Biometric Products
- Sub-Industry: N/A
- Sector: Computer and Technology
- Symbol: NASDAQ:BKYI
- CUSIP: N/A
- Web: www.bio-key.com
- Current Ratio: 2.93%
- Quick Ratio: 2.42%
Sales & Book Value:
- Annual Sales: $2.98 million
- Price / Sales: 4.21
- Book Value: $2.54 per share
- Price / Book: 0.64
- Net Income: $-4,180,000.00
- Net Margins: -106.55%
- Return on Equity: -37.54%
- Return on Assets: -33.31%
- Employees: 21
- Outstanding Shares: 7,690,000
Frequently Asked Questions for BIO-key International (NASDAQ:BKYI)
What is BIO-key International's stock symbol?
BIO-key International trades on the NASDAQ under the ticker symbol "BKYI."
How were BIO-key International's earnings last quarter?
BIO-key International Inc. (NASDAQ:BKYI) issued its quarterly earnings results on Tuesday, November, 14th. The technology company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.11. The technology company earned $0.94 million during the quarter. BIO-key International had a negative net margin of 106.55% and a negative return on equity of 37.54%. View BIO-key International's Earnings History.
When will BIO-key International make its next earnings announcement?
Where is BIO-key International's stock going? Where will BIO-key International's stock price be in 2017?
1 brokers have issued 12-month price objectives for BIO-key International's stock. Their predictions range from $5.50 to $5.50. On average, they expect BIO-key International's share price to reach $5.50 in the next year. View Analyst Ratings for BIO-key International.
Who are some of BIO-key International's key competitors?
Some companies that are related to BIO-key International include ParkerVision (PRKR), Qumu Corporation (QUMU), Rubicon Technology (RBCN), Echelon Corporation (ELON), SemiLEDS Corporation (LEDS), Top Image Systems (TISA), HealthWarehouse.com (HEWA), Sphere 3D Corp. (ANY), Image Sensing Systems (ISNS), One Horizon Group (OHGI), CounterPath Corporation (CPAH), Ability (ABIL), Sierra Monitor Corp. (SRMC), Superconductor Technologies (SCON), RMG Networks Holding Corporation (RMGN), Bridgeline Digital (BLIN), Destiny Media Technologies (DSNY) and P10 Industries (PIOIQ).
Who are BIO-key International's key executives?
BIO-key International's management team includes the folowing people:
- Michael W. DePasquale, Chairman of the Board, Chief Executive Officer (Age 60)
- Cecilia C Welch, Chief Financial Officer (Age 56)
- Barbara Rivera, Chief Operating Officer, Director (Age 64)
- Scott Mahnken, Vice President - Marketing (Age 55)
- Mira K LaCous, Vice President - Technology and Development (Age 54)
- Renat Zhdanov, Chief Scientist (Age 52)
- Thomas E Bush III, Director (Age 63)
- Thomas Gilley, Director (Age 54)
- Pieter Cornelis Knook, Director (Age 59)
- Robert J. Michel CPA, Director (Age 60)
Who owns BIO-key International stock?
Who bought BIO-key International stock? Who is buying BIO-key International stock?
How do I buy BIO-key International stock?
Shares of BIO-key International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is BIO-key International's stock price today?
One share of BIO-key International stock can currently be purchased for approximately $1.63.
How big of a company is BIO-key International?
BIO-key International has a market capitalization of $12.88 million and generates $2.98 million in revenue each year. BIO-key International employs 21 workers across the globe.
How can I contact BIO-key International?
BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL TOWNSHIP NJ, 07719. The technology company can be reached via phone at 732-359-1100 or via email at [email protected]
MarketBeat Community Rating for BIO-key International (NASDAQ BKYI)MarketBeat's community ratings are surveys of what our community members think about BIO-key International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for BIO-key International (NASDAQ:BKYI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$5.50 (237.42% upside)|
Consensus Price Target History for BIO-key International (NASDAQ:BKYI)
Analysts' Ratings History for BIO-key International (NASDAQ:BKYI)
(Data available from 11/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|7/13/2017||Maxim Group||Initiated Coverage||Buy -> Buy||$5.50||N/A|
Earnings History and Estimates Chart for BIO-key International (NASDAQ:BKYI)
Earnings History by Quarter for BIO-key International (NASDAQ BKYI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/30/2018|| || || || || || || || |
|11/14/2017||Q3 2017||($0.17)||($0.28)||$0.94 million||View||N/A|
|8/14/2017||Q2 2017||($0.22)||($0.32)||$0.89 million||View||N/A|
|5/15/2017||Q1 2017||($0.26)||$1.42 million||View||N/A|
|8/14/2015||Q2 2015||$0.01||$2.27 million||View||N/A|
Earnings Estimates for BIO-key International (NASDAQ:BKYI)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for BIO-key International (NASDAQ:BKYI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for BIO-key International (NASDAQ BKYI)
Insider Ownership Percentage: 11.40%
Institutional Ownership Percentage: 2.65%
Insider Trades by Quarter for BIO-key International (NASDAQ BKYI)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/22/2017||Fong Wong Kwok||Insider||Buy||427,778||$3.60||$1,540,000.80|| |
|8/31/2017||Fong Wong Kwok||Insider||Buy||26,300||$3.10||$81,530.00|| |
|4/28/2017||Fong Wong Kwok||Insider||Buy||277,778||$3.60||$1,000,000.80|| |
|11/18/2016||Fong Wong Kwok||Director||Buy||6,200,000||$0.30||$1,860,000.00|| |
|9/16/2016||Fong Wong Kwok||Director||Buy||651,500||$0.25||$162,875.00|| |
|9/15/2016||Fong Wong Kwok||Director||Buy||925,200||$0.25||$231,300.00|| |
|9/13/2016||Fong Wong Kwok||Director||Buy||841,975||$0.24||$202,074.00|| |
|6/15/2016||Fong Wong Kwok||Director||Buy||172,000||$0.28||$48,160.00|| |
|6/13/2016||Fong Wong Kwok||Director||Buy||786,900||$0.29||$228,201.00|| |
|6/10/2016||Fong Wong Kwok||Director||Buy||428,100||$0.28||$119,868.00|| |
|6/9/2016||Fong Wong Kwok||Director||Buy||712,100||$0.26||$185,146.00|| |
|6/7/2016||Fong Wong Kwok||Director||Buy||565,712||$0.23||$130,113.76|| |
|6/2/2016||Fong Wong Kwok||Director||Buy||696,038||$0.22||$153,128.36|| |
|6/1/2016||Fong Wong Kwok||Director||Buy||190,605||$0.18||$34,308.90|| |
Latest Headlines for BIO-key International (NASDAQ BKYI)
BIO-key International (NASDAQ BKYI) Chart for Tuesday, November, 21, 2017